A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS-Like Zebrafish Model

Abstract

BACKGROUND: FSGS affects the complex three-dimensional morphology of podocytes, resulting in loss of filtration barrier function and the development of sclerotic lesions. Therapies to treat FSGS are limited, and podocyte-specific drugs are unavailable. To address the need for treatments to delay or stop FSGS progression, researchers are exploring the repurposing of drugs that have been approved by the US Food and Drug Administration (FDA) for other purposes. METHODS: To identify drugs with potential to treat FSGS, we used a specific zebrafish screening strain to combine a high-content screening (HCS) approach with an in vivo model. This zebrafish screening strain expresses nitroreductase and the red fluorescent protein mCherry exclusively in podocytes (providing an indicator for podocyte depletion), as well as a circulating 78 kDa vitamin D-binding enhanced green fluorescent protein fusion protein (as a readout for proteinuria). To produce FSGS-like lesions in the zebrafish, we added 80 µ M metronidazole into the fish water. We used a specific screening microscope in conjunction with advanced image analysis methods to screen a library of 138 drugs and compounds (including some FDA-approved drugs) for podocyte-protective effects. Promising candidates were validated to be suitable for translational studies. RESULTS: After establishing this novel in vivo HCS assay, we identified seven drugs or compounds that were protective in our FSGS-like model. Validation experiments confirmed that the FDA-approved drug belinostat was protective against larval FSGS. Similar pan-histone deacetylase inhibitors also showed potential to reproduce this effect. CONCLUSIONS: Using an FSGS-like zebrafish model, we developed a novel in vivo HCS assay that identified belinostat and related pan-histone deacetylase inhibitors as potential candidates for treating FSGS. mehr

Mehr zum Titel

Titel	A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS-Like Zebrafish Model
Medien	Journal of the American Society of Nephrology: JASN
Heft	12
Band	34
ISSN	1533-3450
Verfasser	Maximilian Schindler, Florian Siegerist, Tim Lange, Prof. Dr. Stefan Simm, Sophia-Marie Bach, Marianne Klawitter, Jochen Gehrig, Sheraz Gul, Nicole Endlich
Seiten	1977–1990
Veröffentlichungsdatum	12.2023
Zitation	Schindler, Maximilian; Siegerist, Florian; Lange, Tim; Simm, Stefan; Bach, Sophia-Marie; Klawitter, Marianne; Gehrig, Jochen; Gul, Sheraz; Endlich, Nicole (2023): A Novel High-Content Screening Assay Identified Belinostat as Protective in a FSGS-Like Zebrafish Model. Journal of the American Society of Nephrology: JASN 34 (12), 1977–1990. DOI: 10.1681/ASN.0000000000000235